← Evidence map

ArticleBlood2026

Discovery and preclinical activity of the menin-KMT2A inhibitor ziftomenib in acute leukemia models.

Hongzhi Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41849234